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Abstract  Additional NMR data (local NOE ratios and chemical shifts) for endothelin-1 supporting the existence ofa relatively regnlar helix initiated 
abruptly at Lys 9 (with Asp s as an N-cap) and extending inall cases to Cys 15 (and in a frayed form to Asp 18 in some analogs) ispresented. The recent 
solid-state structure [Janes et al. (1994), Nature Struct. Biol. 1, 311-319], incontrast, places the helix in the extreme C-terminal section of the structure 
and the Lysg-Tyr ~3 segment isnot helical. The X-ray structure does not predict he NOEs or chemical shifts observed for endothelins inaqueous 
media containing polar organic o-solvents. An analysis of the chemical shift data for reporter groups indicates that the helical conformational 
preference ofendothelins is not significantly altered by the addition of acetonitrile, acetic acid, or ethylene glycol. The validity of the analytic strategy 
is supported by results for both more rigid and less helical analogs. We conclude that he structure observed incrystals obtained from purely aqueous 
media is influenced by intermolecular interactions inthe solid state and is not a significant contributor to the conformational equilibrium observed 
for monomeric ET-1. 
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1. In t roduct ion  
Endothelins are a family of 21 residue bisdisulfide peptides 
that includes the most potent endogenous vasoconstrictor 
known, ET-1 [1]. 
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Structural and pharmacological studies of the endothelin fam- 
ily of peptides have been one of the most active areas of medic- 
inal research over the last few years [2,3], the number of papers 
on this subject exceeds 2000 by now, but no consensus has been 
reached concerning the stereostructural features associated 
with binding at the different classes of ET receptors [4-6]. 
NMR spectroscopy and X-ray crystallography can provide de- 
tailed information on the solution- or solid-state structure, re- 
spectively, of proteins. ConformationaUy versatile medium- 
sized peptides, such as endothelins, are not as well suited for 
either technique: (i) crystallization is more difficult and inter- 
molecular contacts in crystals with low water content can influ- 
ence the structural preference of a peptide which lacks intra- 
molecular interactions that maintain a single stable structure, 
(ii) conformational versatility (producing multiple populated 
conformers with 20 ns-100 gs lifetimes) and the possibility of 
more rapid motional averaging can be a grave complication i
NOE (nuclear Overhauser effect)-based structure lucidation. 
NMR structures have been reported for most members of the 
endothelin family; in many cases the species have been studied 
in both DMSO (a highly denaturing solvent) and in acidic 
aqueous media with varying quantities of solubilizing organic 
co-solvents added in order to support NMR concentrations 
without producing aggregates [7- 9]. The earlier structural pro- 
posals [10-13] based on data for DMSO solutions have been 
largely discounted; more recent studies [9,14,15] indicate acom- 
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plex conformational mixture is present in DMSO-containing 
media. The consensus feature of the NMR structures for mixed 
aqueous media is a somewhat irregular ~t-helix spanning from 
Lys 9 to at least Cys 15. A C-terminal extension to Leu 17 has been 
reported [16] based on a preliminary analysis of NMR data for 
a more rigid analog, [Pen3.15,NleT]ET-I (henceforth bisPenET), 
which is an ETA-selective agonist. A r-turn encompassing resi- 
dues 5-8 has been reported in a number of studies [7,9,17-19]. 
The orientation of the C-terminus (residues 16~21) relative to 
the bicyclic core and the extent o which conformational aver- 
aging is occurring in that segment remains controversial. An 
X-ray crystal structure has recently been reported for ET-1 [20]; 
in decided contrast to the NMR structures, it displays aregular 
helical structure in the C-terminal fragment and the region from 
Lys 9 to Tyr ~3 does not display helical backbone torsion angles. 
The authors argue that the differences arise either because the 
NMR data were obtained in the presence of organic o-solvents 
or due to inherent problems in the protocols used for deriving 
NOE-based structure nsembles. Distance constrained dynam- 
ics programs can, indeed, be faulted for their inherent assump- 
tion that a single family of similar structures can fit all of the 
NOE data when fast dynamics and/or a conformational equi- 
librium are present. Notably, astring of i/i + 3 constraints (even 
if they are due to transiently formed helical turns in a conforma- 
tional mixture) will produce a helical structure by such proto- 
cols. Lacking an r -6 dependence, chemical shifts are linear pop- 
ulation-weighted averages over a conformational ensemble; 
chemical shift index (CSI) analyses [16,21] may, thus, be a 
better method for conformational mixtures. Herein we: (i) re- 
view the literature chemical shift data for endothelins, (ii) pro- 
vide an extensive new body of experimental data for ET-1 and 
some analogs in a variety of media, (iii) examine other NMR 
diagnostics for helical structuring that do not rely on distance- 
constrained dynamics for structural conclusions, (iv) report he 
NOE-derived structure of a more rigid (and helical) ET-1 ag- 
onist, and (v) point out key NMR observations that cannot be 
explained by the X-ray structure. In sum, the X-ray structure 
is a poor model for rationalizing the solution state NMR data. 
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In our view, the published solid-state conformation can not be 
a significant contributor to the conformational equilibrium pre- 
sented by monomeric ET-1 in the solution. 
2. Materials and methods 
2.1. CSI histograms from previously published NMR data 
Chemical shift data reported in nine papers [7-9,13,15,16,18,19,22], 
and in the Ph.D. thesis of C. Chen (University of Washington, 1992) 
were re-examined for concordance with 2D spectral figures appearing 
in the same reports; afew minor typographic errors and misattributions 
were corrected. In the present study, the shifts are converted to chemical 
shift indices (CSI histograms) by subtracting 'random coil' reference 
shifts from the reported or corrected values. (For mixed aqueous media, 
the Ha random coil reference values which we employ are, with the 
exception of Ile (4.10), Leu (4.28) and Val (4.05), 0.025 _+ 0.031 ppm 
upfield of those reported by Wishart et al. [21]. The HN reference values 
are, with the exception of Asp (8.30) and Phe/Glu (8.23), narrowly 
centered about 8.14 + 0.042 (S.E.M.). All current reference values will 
be provided upon request.) For DMSO data we use the published coil 
values [23]. 
2.2. Experimental methods 
NMR spectra of [AIa3"I,NleT]ET-1, [Ala3'II:,Nle7]ET-1, [Pen TM, 
NleT]ET-1 (bisPenET, obtained from Dr. J.T. Hunt, Bristol-Myers 
Squibb), 20N-Me-bisPenET (also obtained from Dr. Hunt) and native 
ET-1 (Penninsula Labs, Belmont, CA) were recorded at 500 MHz in 
a variety of acidified (TFA or HOAc/HCO2H) media, nominal pH 
3.2-4.2. 2D spectra (NOESY, TOCSY and COSY) were recorded and 
processed using FELIX (Hare Research Inc.) as previously described 
[9,24]. Complete sequence-specific assignments were readily obtained 
using the now standard spin-system/sequencing (TOCSY/NOESY) 
methods of protein NMR [25]. 
2.3 Computational methods 
Models of ET-1 and bisPenET were obtained by constrained dynam- 
ics simulated annealing (XPLOR3.1; PolygerdMolecular Simulations), 
including a standard Lennard-Jones potential rather than a purely 
repulsive van der Waals potential. Exaggerated bond length, angle and 
improper torsional potentials were employed in order to maintain 
standard geometries. In generating specific helical models, ~ and 
dihedrals were constrained innarrow ranges (+ 10") and the NOE force 
constant (kNoE) was decreased so that the Er~oE contribution to ETOTA L 
was less than the term for the constrained dihedrals. The previously 
published [9] distance constraints for ET-1 were employed; those em- 
ployed for bisPenET will appear in a subsequent detailed account of 
the NMR work on a series of bisPen analogs. All computations were 
performed on Silicon Graphics Personal Iris 4D/25TG or Indigo work- 
stations. 
3. Results and discussion 
The major discrepancies between the X-ray structure [20] of 
ET-1 and NMR-derived models [7-9,15,18] are most readily 
apparent upon examining key intermediate-range NOEs. An 
extensive web of i/i+ 3 NOEs appears from residues 9 through 
16 in all published NMR studies in mixed aqueous media. Such 
NOE connectivities are particularly dense and tight between 
Lys 9 and Val ~2 and these are not notably co-solvent dependent; 
for ET-3 at pH 3.6 in the absence of co-solvents, Mills et al. [22] 
report seven through-space contacts between these two key 
residues, all presumably -< 4.5 A. Pertinent NOE distance con- 
straints used to derive the structure of ET-1 in aqueous ethylene 
glycol [9] are given in Table 1. Although the coordinates for the 
X-ray structure have not been published, minimum values for 
these distances (see Table 1) can be measured, or deduced, from 
digitized images of  the structural stereograms in the paper [20]. 
The X-ray structure fails to predict many quite strong NOEs 
in the N-terminal portion of the helix. In other cases, the X-ray 
structure predicts very strong NOEs where much smaller ones 
are observed in the NOESY data for the solution state species. 
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Fig. 1. Inter/intra-residue H~HN NOE ratios for bisPenET in 50% aq. ethylene glycol at 298 K. The Ancl value is the difference in the number of 
contour levels observed for inter- vs. intra-residue NOEs at each HN and Ha chemical shift line using a contour level multiplier of 1.4. The values 
thus correspond to logl.4[inter-NOE/intra-NOE] with positive values indicating the increasing contribution of extended chain conformations atthat 
site. For each residue the measure for the HN line (NOE to ctH vs. a~, predominantly reflecting ~i-~) appears before the measure at the Ha line (NOE 
to Ni+t vs. N i, reflecting ~i). The values expected for a fully disordered and a 100% helical segment are +1.6 and -4.5 + 0.6, respectively; the distances 
in a standard fl-sheet conformation would yield a value of +4.3. 
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The comparisons in Table 1 argue that the X-ray structure 
cannot be the dominant solution state conformer. 
Janes et al. suggest that the organic o-solvents used in NMR 
studies may have altered the conformational preference of ET- 1 
significantly. In the following sections we take up this point by 
using other NMR diagnostics and by ascertaining whether en- 
dothelins could have a rigid low energy conformation that 
includes a regular helix from residues 9 through 16. 
3.1. Other NMR data supporting a helical preference from Lys 9 
to Cys Is 
Previous NMR studies [16] have established that bisPenET 
(a potent agonist) is more helical than native ET- 1, for example 
the exchange half-lives of the backbone NHs from residues 
12-15 are ->10 h under conditions where the most persistent 
NHs (residues 12-14) of native ET-1 have t m values of 1-3 h. 
The increased helicity is also evident by CD [26,27] and by a 
complete uninterrupted set of both aiNi+3 and aifli+3 connectiv- 
ities spanning from residue 9 to 17 [16]. Elimination of the 
3,11-disulfide linkage greatly reduces vasoconstrictor activity 
[26,27,29,30] and net helicity as measured by CD [28-30]. 
Local NOE ratios provide a sensitive and unambiguous 
measure of backbone torsion angle distributions. Bradley et al. 
[31] validated an equation for deriving local fractional helicity 
from NiNi+l/0~iNi+ 1 NOE ratios; we have extended the method 
to aiNi]ai_lNi and aiN~/aiNi+~ ratios [16]. Fig. 1 shows the inter/ 
intra-residue Ha/HN NOE ratios for bisPenET in 50% aqueous 
glycol. The residue-by-residue contributions of local extended 
conformations are judged to be uniformly less than 15% from 
Lys 9 to Cys ~5, with helicity estimates approaching 100% at 
several loci. Helicity estimates for residues 16--18 decrease but 
remain in excess of 40%. A similar plot for native ET-1 shows 
the same features from residue 2 through 15 but the contribu- 
tion of extended conformations in the helical portion of that 
span is judged to be somewhat greater, perhaps as much as 
25%. Beyond Cys ~5, all of the Ancl values for native ET-1 are 
equal to or greater than +0.5, indicating less helicity in the 
C-terminal portion of the structure. 
Chemical shift is very sensitive to the spatial disposition of 
hydrogens relative to zt systems including the amide function; 
as a result, chemical shifts change dramatically with alterations 
in backbone conformation. It is now well established that local 
helical preferences produce upfield shifts for the ct-methine 
proton resonance [21,32,33]. Histograms of aCSIs over a helical 
span of a peptide typically reach values of -0.4 ppm at the 
center of the helix with smaller upfield shifts at the frayed ends. 
Fig. 2 collects aCSI and HN-CSI histograms for endothelins 
in aqueous glycol and aqueous acetic acid. The HN-CSI plots 
are included since HN shifts yield even larger deviations as 
peptide segments go from a disordered to an ordered state. 
(The direction of HN shift deviations is largely dependent on 
H-bonding and coulombic interactions and cannot be corre- 
lated with an a or fl conformational preference.) 
Fig. 2A shows the CSI histograms derived from our data for 
native ET-I, the more persistently structured bisPen analog and 
a more flexible [Ala 3,1~] analog. The Ha CSI histogram of the 
bisPenET analog reveals a more extensive (and presumably, 
less dynamic) helical conformation, while that for the 1,15- 
monodisulfide shows increased contributions by more extended 
local conformations in the 'helical' span. For bisPenET, the 
comparison of the data with and without added hexafluoroiso- 
propanol shows that the increased helicity in the fluoroalcohol- 
containing medium reflects propagation further into the 
C-terminal fragment. An examination of the Ha and HN-CSI 
profiles in the Cys3~Asp s loop for this series of compounds 
indicates that the increased helix predominance from residue 
9 ~ 15 is coupled to a structuring transition in the loop region. 
Since bisPenET is more rigidly structured and still retains full 
agonist activity, we view structures generated from NMR data 
for this analog as a superior model for the bioactive conforma- 
tion of endothelins. 
Published studies from other laboratories provide additional 
insights into the helical domain of endothelins: Dalgarno et al. 
[18] compared ET-1 with M7A and D8A mutants in 40% aq. 
acetic acid; Coles et al. [19] have reported shift data for a 
3,11-monodisulfide, [(ct-aminobutyric a id)l'~5]ET-1, in 10% 
acetonitrile. Fig. 2B re-states the literature data as CSI histo- 
grams. Coles et al. concluded, based on NOE-constrained sim- 
ulated annealing calculations (XPLOR3.0), that the conforma- 
tion in the helical span was the same as that we reported for 
ET-I; however, the a-CSI plot suggests that the elimination of 
the 1,15-disulfide increases the contribution of local extended 
conformations throughout the helical region, and eliminates 
the large downfield shift at 15-HN. The data of Dalgarno et al. 
clearly reveal that the AspS~ Ala s substitution reduces the aH 
up field shifts in the helical span, and also moderates all devia- 
tions from random coil values in the Ser 4 ~ Leu 6 portion of the 
loop region: precisely as seen in the more flexible mono-disul- 
fide structures. We suggest hat this is strong evidence for a 
helix N-capping role for Asp s and that this structural feature 
should be included in models of the solution-state conforma- 
tion of endothelins. Although the pivotal position of Asp s was 
noted by Dalgarno et al., the specific N-capping role was not 
proposed. 
3.2. Is the helical preference from Lys ° to Cys 15 medium 
dependent? 
We employ 9Ha, 12Ha, and 14Ha as reporter groups to 
ascertain the extent o which the organic co-solvents used in 
NMR studies influence helical preferences in this region. At the 
top of Table 2, the data for two bisPen analogs and a more 
flexible [Ala 3'"] analog are given. In the central portion of Table 
2, data for ET-1 in different mixed aqueous media are pre- 
sented. The solvent mixtures are listed in order of increasing 
lipophilicity as judged by the chemical shift of the Ile~9-y2 reso- 
nance*. Based on the reporter group shifts, the helix in native 
ET-1 is slightly less populated than in the bisPen analogs. The 
shift data also indicate that the polar organic solvents used for 
NMR investigations do not alter the fractional helicity signifi- 
cantly. Glycol addition produces a slight increase in helicity 
based on this analysis and this has been confirmed by CD 
studies [9,26,27]. A more detailed analysis of the helix-indicat- 
*In increasingly lipophobic media, the I1el9-72 resonance appears 
upfield due to shielding by the Trp 21 indole ring. The experimental 
evidence for this C-terminal structuring feature, which is present in all 
endothelins examined to date and in fragments (such as HLDIIW, 
AcCHLDIIW and VYFAHLDIIW) lacking the disulfide-linked core 
of natural endothelins, will be presented elsewhere. The effect of in- 
creasing interaction of the indole ring and the fatty side chain is remi- 
hiscent of the observed shift changes in the cyclic pentapepfide ET 
antagonist BQ-123, where a Leu-y proton appears nearly 1 ppm upfield 
from its random coil value in media of high water content [34]. 
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Fig. 2. CSI histograms for endothelins from residue 3through 18; the C-terminal residues were excluded from these plots since the deviations were 
small and essentially the same for all of these species and for C-terminal fragments lacking the disulfide-linked ndothelin core structure. (A) Ha 
(to the left) and HN-CSI plots vs. residue number for (left-to-right a each residue number) bisPenET (black bars, in 14% HFIP, 43% ethylene glycol, 
43% H20, pH 3.5, 292 K; hatched bars, 50% ethylene glycol, pH 3.5, 298 K), native ET-1 (black bars, 60% ethylene glycol, pH 3.2, 307 K) and 
[Ala3'U']7,NIeT]ET-1 (grey bars, 65% ethylene glycol, pH 4.2, 305 K). HN chemical shifts have been corrected to 298 K based on the measured 
temperature gradients. All reference d~ values for Ha have been increased by 0.04 ppm for the HFIP-containing medium, reflecting measured HFIP 
bulk solvent effects on shifts of structured proteins and fully disordered peptides examined inthis laboratory. (B) CSI histograms for (left-to-right 
at each residue number) [Ala7]ET-1 and [AlaS]ET-I (both in 40% acetic acid, 298 K), and [AbatJS]ET-1 (50% acetonitrile, 1.5% acetic acid, 298 K) 
based on the literature chemical shift data [18,19]. 
ing upfield H0t shifts, including the small effects of the added 
co-solvents upon the random coil reference values, indicates 
that 50 + % acetonitrile and 40% acetic acid actually decrease 
the helix population slightly. 
Conformational changes produced by the addition of the 
polar organic solvents to water for NMR studies do not appear 
to provide a rationale for the discrepancies between the NMR 
structures and the X-ray structure. In distinct contrast, he data 
for DMSO solutions reveal substantial disruption of the helix; 
but even in this highly denaturing solvent, upfield ¢t chemical 
shift deviations are observed at Lys 9 and Va112, indicating sig- 
nificant local ¢t conformational preferences are still present. 
3.3. Why is the helix from Lys 9 to Cys 15 not found in the solid- 
state structure of ET-l? 
Several explanations can be offered. For one, it could be 




range contacts absent in the X-ray struc- 
Connectivity NOE distance X-ray structure 
constraint [9] (A) distance (A) 
From the helical region 
9 HAJ12 HB 2.4-2.75 >8 
9 HA/12 HG2* 2.55-3.25 >7.5 
9 HAJI2 HGI* 3.2-4.4 >9 
9 HA/12 HN 2.9-3.7 >6 
9 HA/13 HN 3.65-5.5 >8 
10 HA/13 HN 3.2-3.7 >5.5 
10 HA/13 HB* 2.9-3.65 ->5 
10 HA/14 HN 3.55-4.35 >6.5 
11 HA/14 HN 3.2-4.8 > 5.5 
12 HA/17 HN 3.2-3.8 ~>5 
13 HA/15 HN 3.5-4.6 >5.5 
13 HA/16 HN 3.35-3.9 >6 
From other regions 
5 HN/11 HB* 3.1-3.9 > 5.5 
5 HB*/7 HN 3.2-4.25 >6 
6 HA/12 HG2* 2.6-3.5 >8 
12 HGI*/16 HD2 3.0-4.0 >7.5 
19 HA/20 HN 2.05-2.55 > 3.2 
19HG2"/21 HN 3.35-4.75 > 6.5 
Close contacts predicted by the X-ray structure 
12 HA/14 HN 3.6~.7 <2.5 
12 HAJ13 HN 3.3-3.65 ~2.4 
13 HN/14 HN 2.75-3.11 < 1.9 
6 HA/7 HN 2.8-3.45 <2.3 
An asterisk following a proton label indicates a wildcarded set of 
equivalent, shift coincident, or stereochemically unassigned prochiral 
hydrogens. The distances reported correspond to an < r -6 > average is 
such instances. 
argued that a regular ct helix from Lys 9 to Cys ~5 is not a stable 
conformation; that the steric and covalent constraints of native 
ET-1 and bisPenET preclude this as an energy well structure. 
If this were the case, the NMR data could reflect a 'dynamic 
helix' in which a non-helical segment appears at different loci 
in the resulting solution-state conformational mixture and one 
of these less helical forms could be that observed in the solid 
state. Alternatively, the solid-state structure may be the result 
of interactions that are not present in the monomeric solution- 
state conformational mixture. We have probed this question by 
comparing NOE constraint violations and constraint-induced 
structural distortions for parallel simulated annealing runs with 
and without torsion constraints that enforce a regular helical 
geometry from Lys 9 to His ~6. The backbone torsion angles that 
result for bisPenET from the two simulations appear in Fig. 3. 
We selected this more rigid analog for the illustration since the 
added geminal dimethyl groups present make it the species 
most likely to show steric interactions that preclude certain 
regions of conformational space. Comparable results were ob- 
tained with native ET-1 (data not shown); however, the struc- 
ture derivation with heavily weighted NOE constraints pro- 
duces greater backbone torsion variability at residues 15 and 
16. 
In order to draw conclusions concerning the relative struc- 
ture-distorting effects of NOE constraints vs. helical torsion 
angles, the force constants for the NOE and constrained ihe- 
dral potentials were adjusted so as to yield the same net con- 
straint contribution (82 + 12 kcal/mol) to ETOTAL. In the proto- 
col enforcing helical geometries (C/g, + < 10°), the ENoE term 
represented only 33 + 2% of the total constraint contribution 
to ETOTAL; in the structure derivation with a reduced k~dih term, 
the ENOE term contributed fully 90 + 6% of the constraint con- 
Table 2 
Ile19-72 and helix reporter group chemical shifts 
Lys-ct Val-~; 7,7" Phe-ct 1972 shift Conditions 
Most helical 
3.84 3.37; 1.01, 0.81 4.30 0.28 b 
3.86 3.35; 1.02, 0.81 4.25 0.64 b 
Less helical 
4.08 3.85; 0.86, 0.76 4.52 0.62 
Media effects, mixed aqueous conditions 
3.92 3.54; 1.02, 0.89 4.21 0.51 
(4.00 3.74; 0.86, 0.80) ~ n.a. 0.52 
3.90 3.49; 0.99, 0.840 4.23 0.53 
3.89 3.50; 0.975, 0.835 4.195 0.605 
3.91 3.59; 0.97, 0.84 4.27 0.61 
3.95 3.58; 1.02, 0.89 4.28 0.62 
3.94 3.51; 0.97, 0.83 4.27 0.63 
3.85 3.52; 0.94, 0.81 4.20 0.67 
3.895 3.59; 0.93, 0.80 4.25 0.695 
DMSO media 
3.94 3.85; 0.80, 0.74 4.40 0.73~0.75 
4.06 3.99; 0.76, 0.71 4.52 0.74 
4.29 4.26; 0.98, 0.92 4.56 0.86 
50% glycol, 298 K, 20NMe-bisPenET a 
50% glycol, 298 K, bisPenET ~'d 
65% glycol, 305 K, [Ala3'll't7,Nle 7] ET-1 a 
10% CD3CO2H , 293 K, [7] 
H20, 303 K, [22] (ET-3) 
40% glycol, 295 K a 
60% glycol, 307 K c 
30% CD3CN, 303 K, [8] 
40% CD3CO2H, 298 K, [18] 
75% glycol, 305 K ~ 
50% CD3CN, 298 K, [15] [Nle 7] 
80% CD3CN, 303 K a 
90-100% DMSO, 295-310 K d'f 
93% DMSO, 295 K, [Ala3'lI,Nle7]ET-1 a 
DMSO reference values 
Aqueous reference valuesa: Lys-a, 4.33; Val-ct 7, 7", 4.05; 0.91, 0.75; Phe-a, 4.60; Ile-72, 0.77. 
aPreviously unreported ata from this laboratory. 
bThis dramatic hange in chemical shift for I1e-72 remains unexplained. The 20N-Me analog is an ETA receptor-selective antagonist (unpublished 
observations of J.T. Hunt at Bristol-Myers Squibb, Princeton, NJ). 
CPublished ata from this laboratory [9,16]. 
dData from this laboratory, previously reported in the Ph.D. thesis of C. Chen (University of Washington, 1992). 
eEntirely comparable chemical shifts are not expected for ET-3 due to the local effects of nearby ET-1 to ET-3 residue substitutions - M7K, F14Y 
and possibly L6Y. 
fThese chemical shifts are in full accord with values previously reported for this medium [13,15]. 
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Fig. 3. Plots of ~/i vs. residue number (i) for bisPenET models with varying relative weights for the NOE constraints and a set of torsion constraints 
forcing standard helical ~/g values from residue 9to 16. Panel A shows the result for forcing torsion constraints, and panel B that for heavily weighted 
NOE constraints. The corresponding [-~t] values (and + S.E.M.) are shown below each trace for the helical domain. The ensemble average (and 
+ S.E.M.) values of NOE distance rms violation, EIMm and EvDw are inserted for each ensemble. For panel A the wide variance in gi (and ~, not 
shown) values for the Cys3~ Nle 7 indicates that several unstrained conformers of the loop are compatible with a helical conformation from residue 
9 to 16. In the plot for heavily-weighted NOEs, a consensus conformation is also apparent for the SetS-Asp s region. 
tribution to ETOTA L. Structural distortions caused by the con- 
straints appeared exclusively in the EIMPR and EvDw terms, the 
angle and bond rms terms were identical and indicated no 
significant distortions from normal geometry (+2.5 ° and 
+0.007/~, respectively). 
The increased NOE violation rms in the helical state model 
and the structural distortions that result when the kNo E term 
is heavily weighted, indicate that some mutually inconsistent 
NOEs are observed ue to residual dynamics in the solution 
state. The helical structures display less distortions than those 
produced when the kNo E term is increased. Modeling thus sug- 
gests that endothelins could adopt a 'static' and quite regular 
146 G.M. Lee et al./FEBS Letters 355 (1994) 140-146 
helical conformation. Clearly, another ationale is required in 
order to explain the conformational features for the Asp s_ 
Tyr 13 segment in the X-ray structure. 
The ET-1 crystals examined by X-ray were obtained from 
water with no added solvents, urfactants orbuffers. It has been 
reported [35,36] that ET-1 aggregates inpure water at concen- 
trations exceeding 22/tM. Janes et al. [20] note a 'dimer contact' 
which buries 800/~2 of surface area in the solid-state structure 
with the closest backbone-backbone distances at residues 12- 
13. An intermolecular H-bond, TyrlS-OH---~O = C-Asp s was 
also noted in that paper. The structural figures uggest that the 
fatty side chains of Va112 and Met 7 could also be in the contact 
region of the dimer. We suggest hat crystallization from a 
medium in which the peptide is present as an aggregate has 
resulted in a dimer structure in which an intermolecular hydro- 
phobic cluster has provided sufficient stabilization toovercome 
the helical propensity of the Lys9---~Tyr 13 span in the monom- 
eric state. As a result, the X-ray structure of ET-1 is a poor 
model for the solution state conformational mixture. The short 
proton-proton distances found in the crystal structure, which 
are not confirmed by NOEs in the solution state, suggest that 
the solid-state conformer is not significantly populated in the 
solution state conformational equilibrium of endothelin mono- 
mers. 
In summary, the NMR data given herein indicate that intact 
monomeric endothelins have a substantial helical conformation 
preference from Lys 9 to Cys ~5 which can partially propagate 
into the nearby portion of the C-terminal appendage. As the 
helical span gains stability and structural regularity, a single 
(but still not fully defined) structure dominates increasingly in
the residue 4~ 8 loop region. The consensus structure for this 
loop [¢6 = -85 + 17, ~/)t 6= -1 + 19, ~7 = -76 + 18, ~//7 =
63 + 19] evident in Fig. 3B bears some resemblance to a type 
I fl-turn. NMR data also indicate that the conformational equi- 
librium for the extreme C-terminus (Asp ts ~Trp  2~) in the solu- 
tion state is not influenced by its attachment to the bisdisulfide- 
linked core. It remains to be determined how relevant these 
solution-state structural features are to endothelin pharmacol- 
ogy. 
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